PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Skin Health Institute, Carlton, Victoria, Australia.\', \'Waikato Hospital - Waikato Clinical Campus University of Auckland\'s Faculty of Medical and Health Sciences Hamilton, Hamilton, New Zealand.\', \'The University of Melbourne - Dermatology Fitzroy, Fitzroy, Victoria, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ajd.13313
?:hasPublicationType
?:journal
  • The Australasian journal of dermatology
is ?:pmid of
?:pmid
?:pmid
  • 32255510
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32255510>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32255510>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all